Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties

Area of Science:

• Microbiology
• Biochemistry
• Peptide Chemistry

Background:

• Natural antimicrobial peptides (AMPs) like RIWVIWRR-NH2 (Bac8c) possess broad-spectrum antibacterial activity.
• Modifying AMPs with hydrophobic ligands can enhance their antimicrobial properties and therapeutic potential.
• Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) are significant human pathogens, often forming resistant biofilms.

Purpose of the Study:

• To synthesize and characterize lipoic acid-modified Bac8c (LA-Bac8c).
• To evaluate the enhanced antimicrobial and antibiofilm activity of LA-Bac8c against S. aureus and MRSA.
• To elucidate the mechanism of action of LA-Bac8c on bacterial membranes.

Main Methods:

• Synthesis of LA-Bac8c by conjugating lipoic acid to Bac8c.
• Determination of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) assays.
• Antibiofilm activity assays and microscopy to observe bacterial/biofilm interaction.
• Membrane depolarization and outer membrane permeabilization assays.

Main Results:

• LA-Bac8c demonstrated significantly lower MIC and MBC values against S. aureus and MRSA compared to unmodified Bac8c.
• LA-Bac8c exhibited superior antibiofilm activity against both established and forming biofilms of S. aureus and MRSA.
• Microscopy revealed direct interaction of LA-Bac8c with bacteria and biofilms.
• LA-Bac8c induced potent membrane depolarization and outer membrane permeabilization, leading to bacterial cell lysis and leakage of cellular components.

Conclusions:

• LA-Bac8c represents a promising modified antimicrobial peptide with enhanced activity against Gram-positive bacteria, including S. aureus and MRSA.
• The enhanced efficacy of LA-Bac8c is attributed to its potent membrane-disrupting mechanism.
• LA-Bac8c holds significant potential for therapeutic applications in combating bacterial infections and biofilms.